News

Zydus Lifesciences and its various subsidiaries has invested balance 9.01 crore for subscription of 90,17,848 equity shares under Tranche 2, 3 and 4 of Torrent Urja 25, representing 22.06% of its paid-up share capital. Pursuant to the same, the transaction of subscription of shares of Torrent Urja 25 is consummated on 19 May 2026. In June 2025 under Tranche 1, the company and its subsidiaries had invested Rs 3.86 crore for subscription of 38,64,792 equity shares of Torrent Urja 25, representing 22.06% of its paid-up share capital.

Zydus Lifesciences announced that the Annual General Meeting(AGM) of the company will be held on 11 August 2026.

Zydus Lifesciences announced that the Board of Directors of the Company at its meeting held on 19 May 2026, inter alia, have recommended the final dividend of Rs 1 per equity Share (i.e. 100%) , subject to the approval of the shareholders.

Net profit of Zydus Lifesciences rose 8.68% to Rs 1272.50 crore in the quarter ended March 2026 as against Rs 1170.90 crore during the previous quarter ended March 2025. Sales rose 18.19% to Rs 7434.40 crore in the quarter ended March 2026 as against Rs 6290.20 crore during the previous quarter ended March 2025.For the full year,net profit rose 11.37% to Rs 5040.00 crore in the year ended March 2026 as against Rs 4525.50 crore during the previous year ended March 2025. Sales rose 18.37% to Rs 26719.70 crore in the year ended March 2026 as against Rs 22573.80 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales7434.406290.20 18 26719.7022573.80 18 OPM %34.3633.79 -31.7231.27 - PBDT2565.602129.50 20 8545.707162.10 19 PBT2057.201891.60 9 7137.706246.30 14 NP1272.501170.90 9 5040.004525.50 11 Powered by Capital Market - Live News

The board of Zydus Lifesciences at its meeting held on 19 May 2026 has approved the proposal to buyback up to 95,65,217 fully paid up equity shares of the company at a price of Rs 1,150 per equity share payable in cash for an aggregate amount not exceeding Rs 1100 crore.